For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) closed at $42.78 down -2.53% from its previous closing price of $43.89. In other words, the price has decreased by -$2.53 from its previous closing price. On the day, 0.61 million shares were traded. RARE stock price reached its highest trading level at $44.6 during the session, while it also had its lowest trading level at $41.99.
Ratios:
For a deeper understanding of Ultragenyx Pharmaceutical Inc.’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.28 and its Current Ratio is at 2.43. In the meantime, Its Debt-to-Equity ratio is 6.65 whereas as Long-Term Debt/Eq ratio is at 6.25.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Goldman on June 06, 2024, Upgraded its rating to Buy and sets its target price to $67 from $56 previously.
On April 22, 2024, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $77.
On December 08, 2023, Wells Fargo started tracking the stock assigning a Overweight rating and target price of $72.Wells Fargo initiated its Overweight rating on December 08, 2023, with a $72 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jul 02 ’24 when Sanders Corazon (Corsee) D. sold 584 shares for $40.98 per share. The transaction valued at 23,932 led to the insider holds 12,009 shares of the business.
Parschauer Karah Herdman sold 9,806 shares of RARE for $441,270 on Jun 12 ’24. The EVP and Chief Legal Officer now owns 57,981 shares after completing the transaction at $45.00 per share. On Jun 10 ’24, another insider, Sanders Corazon (Corsee) D., who serves as the Director of the company, sold 1,737 shares for $41.10 each. As a result, the insider received 71,391 and left with 7,248 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RARE now has a Market Capitalization of 3874550272 and an Enterprise Value of 4073818624. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.75 while its Price-to-Book (P/B) ratio in mrq is 25.34. Its current Enterprise Value per Revenue stands at 9.205 whereas that against EBITDA is -7.396.
Stock Price History:
The Beta on a monthly basis for RARE is 0.56, which has changed by -0.009722233 over the last 52 weeks, in comparison to a change of 0.22226071 over the same period for the S&P500. Over the past 52 weeks, RARE has reached a high of $54.56, while it has fallen to a 52-week low of $31.52. The 50-Day Moving Average of the stock is 3.74%, while the 200-Day Moving Average is calculated to be -0.02%.
Shares Statistics:
For the past three months, RARE has traded an average of 879.34K shares per day and 727330 over the past ten days. A total of 90.57M shares are outstanding, with a floating share count of 85.33M. Insiders hold about 5.79% of the company’s shares, while institutions hold 89.71% stake in the company. Shares short for RARE as of 1719532800 were 4235727 with a Short Ratio of 4.82, compared to 1717113600 on 4465450. Therefore, it implies a Short% of Shares Outstanding of 4235727 and a Short% of Float of 5.38.
